These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 3496311)

  • 1. Enhancement of misonidazole chemopotentiation by mild hyperthermia (41 degrees C) in vitro and selective enhancement in vivo.
    Mulcahy RT; Gipp JJ; Tanner MA
    Int J Radiat Biol Relat Stud Phys Chem Med; 1987 Jul; 52(1):57-65. PubMed ID: 3496311
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Misonidazole-induced chemopotentiation of 1-(2-chloroethyl)-3-cyclohexyl-1-nitrosourea toxicity in O6-methylguanine-DNA methyltransferase proficient (Mer+) and deficient (Mer-) cell lines.
    Mulcahy RT
    Cancer Res; 1986 Jun; 46(6):2892-7. PubMed ID: 3698015
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cross-link formation and chemopotentiation of EMT-6/Ro cells exposed to MISO after CCNU treatment in vitro.
    Mulcahy RT
    Int J Radiat Oncol Biol Phys; 1986 Aug; 12(8):1389-92. PubMed ID: 3759561
    [TBL] [Abstract][Full Text] [Related]  

  • 4. In vivo chemosensitization by misonidazole in sensitive and resistant tumor lines.
    Mulcahy RT; Siemann DW
    Cancer Res; 1983 Oct; 43(10):4709-13. PubMed ID: 6883329
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Enhanced tumor responses through therapies combining CCNU, MISO and radiation.
    Siemann DW; Hill SA
    Int J Radiat Oncol Biol Phys; 1984 Sep; 10(9):1623-6. PubMed ID: 6480451
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Chemopotentiation in vivo: no loss of sensitization with fractionation.
    Hill SA; Siemann DW
    Br J Cancer; 1984 Oct; 50(4):509-17. PubMed ID: 6487517
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The effect in the KHT sarcoma of CCNU and MISO on cell cycle progression evaluated by flow-cytometry.
    Hill SA; Bauer KD; Keng PC; Siemann DW
    Int J Radiat Oncol Biol Phys; 1984 Sep; 10(9):1619-22. PubMed ID: 6480450
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Combinations of CCNU, MISO, and fractionated radiotherapy.
    Siemann DW; Alliet KL
    Int J Radiat Oncol Biol Phys; 1986 Aug; 12(8):1379-82. PubMed ID: 3759559
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Response of murine tumours to combinations of CCNU with misonidazole and other radiation sensitizers.
    Siemann DW
    Br J Cancer; 1982 Feb; 45(2):272-81. PubMed ID: 6460517
    [TBL] [Abstract][Full Text] [Related]  

  • 10. In vivo interaction between radiation and 1-(2-chloroethyl)-3-cyclohexyl-1-nitrosourea in the absence or presence of misonidazole in mice.
    Siemann DW; Maddison K; Wolf K; Hill SA; Keng PC
    Cancer Res; 1985 Jan; 45(1):198-202. PubMed ID: 3965132
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of oxygen on misonidazole chemosensitization and cytotoxicity in vitro.
    Mulcahy RT
    Cancer Res; 1984 Oct; 44(10):4409-13. PubMed ID: 6467202
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Misonidazole and CCNU: further evidence for a pharmacokinetic mechanism of chemosensitization and therapeutic gain.
    Lee FY; Workman P
    Br J Cancer; 1984 May; 49(5):579-85. PubMed ID: 6722006
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Potentiation of CCNU activity by misonidazole in metastases.
    Siemann DW; Alliet KL
    Clin Exp Metastasis; 1987; 5(1):57-63. PubMed ID: 3829497
    [TBL] [Abstract][Full Text] [Related]  

  • 14. In vivo combination of misonidazole and the chemotherapeutic agent CCNU.
    Siemann DW
    Br J Cancer; 1981 Mar; 43(3):367-77. PubMed ID: 7225287
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Chemosensitization by misonidazole in CCNU-treated spheroids and tumours.
    Durand RE; Chaplin DJ
    Br J Cancer; 1987 Aug; 56(2):103-9. PubMed ID: 3663461
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Survival in subpopulations of cells derived from solid KHT sarcomas by centrifugal elutriation following treatment with CCNU and MISO.
    Hill SA; Keng PC; Siemann DW
    Int J Radiat Oncol Biol Phys; 1984 Sep; 10(9):1615-8. PubMed ID: 6480449
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Enhancement of CCNU cytotoxicity by misonidazole: possible therapeutic gain.
    Hirst DG; Brown JM; Hazlehurst JL
    Br J Cancer; 1982 Jul; 46(1):109-16. PubMed ID: 7201845
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparative study of thermoradiosensitization by misonidazole and metronidazole in vivo: antitumour effect and pharmacokinetics.
    Wong KH; Maezawa H; Urano M
    Int J Hyperthermia; 1992; 8(5):645-58. PubMed ID: 1402141
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of misonidazole or metronidazole pretreatment on the response of the RIF-1 mouse sarcoma to melphalan, cyclophosphamide, chlorambucil and CCNU.
    Twentyman P; Workman P
    Br J Cancer; 1982 Mar; 45(3):447-55. PubMed ID: 7073938
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Potentiation of combination chemotherapy by nitroheterocyclics.
    Siemann DW; Allalunis-Turner MJ
    Int J Radiat Oncol Biol Phys; 1988 Jul; 15(1):129-34. PubMed ID: 3391809
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.